Cannabis producer HEXO Corp. (NASDAQ: HEXO) has reported a narrower net loss for the second quarter of 2023, on an adjusted basis, amid a sharp fall in operating expenses. The Canada-based company’s revenues declined during the three-month period.
Comprehensive loss narrowed sharply to C$11.1 million in the January quarter from C$690.3 million in the corresponding period of fiscal 2022.
At C$24.2 million, net revenues were down 54% year-over-year, reflecting lower sales across all the main operating segments. Total operating expenses declined 96% year-over-year.
“SG&A spending is down 11 percent or $1.5 million compared to the previous quarter. We also made significant progress in our trade accounts receivable with a $21 million reduction compared to the first quarter and have paid off $40.7 million in debt,” said Hexo’s CFO Julius Ivancsits.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted
Unicycive is all-in on kidney care, focusing on underserved areas: CEO
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is a biotech firm engaged in the development of novel treatment options for patients with renal diseases. In an email interview with AlphaStreet, CEO Dr.
Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to
